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Reply to Gautret et al
To the Editor—We thank Gautret et al 
for their comments and interest in our 
work. We found it compelling to see the 
Web of Science data that illustrated the ac-
celeration of scholarly publications at the 
intersection of climate change and vec-
tor-borne disease. This trend is perhaps 
unsurprising, considering that each of the 
last 3 decades has been successively warm-
er at the Earth’s surface than any preced-
ing decade since 1850, and well-accepted 
science has demonstrated the devastating 
ecologic effects of these changes [1].
However, we do not agree with their 
2 primary arguments. First, Gautret 
et al imply that a recent decline in vec-
tor-borne disease morbidity and mortal-
ity is evidence for a lack of an association 
between global climate change and these 
conditions. Such ecological inferences 
are highly prone to correlation with-
out causation, much like associations 
between vaccine use and autism risk. 
While we agree that there has been a 
precipitous decline in malaria and other 
neglected tropical disease deaths of late, 
to suggest that this is proof that climate 
change does not impact their control 
ignores the fact that, from 2005 to 2015, 
global financing for malaria control 
more than doubled between 2005 and 
2014, from an estimated $960 million 
to $2.5 billion [2, 3]. Additionally, this 
argument fails to acknowledge that 
artemisinin-based combination thera-
pies became newly available during this 
period, largely resolving the scourge 
of chloroquine resistance [4]. Indeed, 
studies like ours, in western Uganda, 
which demonstrated increased trans-
mission after severe flooding, as well as 
other studies from highland regions of 
Ethiopia and Columbia, which provided 
evidence for an increase in the altitude 
of malaria distribution in warmer years 
[5], are precisely the sort of data that 
demonstrate that climate change can 
thwart our best efforts to eliminate the 
burden of malaria.
However, we take particular excep-
tion to their second point—that the sci-
entific community is overly concerned 
with global climate change. While the 
spread of malaria into new areas may 
currently contribute a small number 
of cases to the global burden of dis-
ease, affected populations, with little 
acquired immunity, will disproportion-
ately suffer. Moreover, the extension of 
vector-borne diseases into new environ-
ments can have disastrous consequences 
for both disease control and elimination, 
as seen in the recent global distribution 
of dengue virus, chikungunya virus, and 
Zika virus [6]. Unfortunately, as with 
many diseases of poverty, those who 
are affected most are likely to be those 
with the fewest resources to respond. 
Therefore, we propose that the high level 
of interest in relationships between cli-
mate change and vector-borne diseases 
is both warranted and just. Indeed, we 
believe that the scientific community 
must maintain strict adherence to both 
the scientific method and the precau-
tionary principle to ensure accurate and 
appropriate focus on the subject [7].
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